news
Baylor College opens xenoliver transplant center, new CRISPR service
Baylor College of Medicine is establishing a Xenoliver Transplant Center to explore pig-to-human liver transplants for end-stage liver disease. Separately, Charles River Laboratories launched a new CRISPR screening service using their 'Calla Lily' tech, aiming to speed up drug discovery for various conditions.
Baylor College of Medicine is establishing a Xenoliver Transplant Center to explore pig-to-human liver transplants for end-stage liver disease. Separately, Charles River Laboratories launched a new CRISPR screening service using their 'Calla Lily' tech, aiming to speed up drug discovery for various conditions.
The architecture take
The new xenoliver transplant center at Baylor is one to watch. If we can solve rejection and disease transmission, pig organs could change the game for hundreds of thousands of people stuck on transplant lists, especially for something as critical to metabolic health as the liver. Right now, organ donation is a huge bottleneck for longevity and quality of life for folks with end-stage disease. CRISPR screening from Charles River Labs sounds less sexy, but it's really just turning up the dial on drug discovery. The faster we pinpoint genes driving disease, the faster we get targeted treatments. I hear people dismiss biotech as too far off to matter for their daily routine, but breakthroughs like these eventually trickle down to new protocols and medications that impact nervous system regulation, metabolic function, and overall healthspan. It's how new peptides and GLP-1s started, after all.